John Libbey Eurotext

Epileptic Disorders

The Educational Journal of the

Role of levetiracetam in the treatment of epilepsy Volume 5, supplément 1, Supplement, May 2003

Auteurs
Epilepsy Unit, Division of Cardiovascular and Medical Sciences, Western Infirmary, Glasgow, Scotland, United Kingdom Penn Epilepsy Centre, Department of Neurology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA
  • Mots-clés : antiepileptic drugs, epilepsy, levetiracetam, seizures
  • Page(s) : 65-72
  • Année de parution : 2003

Physicians treating patients with epilepsy have a host of therapeutic options. Drug choice is dictated first by the seizure(s) and\or epilepsy syndrome. Age is also a factor. Special considerations apply to women, particularly during their childbearing years, and to patients who are learning‐disabled. Drug selection is further influenced by such characteristics as spectrum of activity, rapid response, low potential for drug‐drug interactions, and ease of use. In addition to clinical trial data, postmarketing assessments of the new antiepileptic drugs provide useful clinical information on efficacy and safety. Levetiracetam has specific characteristics that make it an optimal choice for many patient populations.